Experienced in Hemangioma Thrombocytopenia Syndrome

Ivan Vulev

Bratislava, BL, SK 
Experienced in Hemangioma Thrombocytopenia Syndrome
Bratislava, BL, SK 
OverviewLocationsClinical Research

Overview

Ivan Vulev practices in Bratislava, Slovakia. Mr. Vulev is rated as an Experienced expert by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. His top areas of expertise are Thoracic Aortic Aneurysm, Hemangioma Thrombocytopenia Syndrome, Thrombectomy, and Orchiectomy.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Bratislava, BL, Slovakia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Procedure, Device
Prospective, Single-arm, Multi-center, Observational Study to Further Confirm Safety and Efficacy of the Dual-layer Micromesh Roadsaver Stent for the Treatment of Carotid Artery Stenosis in Patients Eligible for Elective Stenting Procedure
Prospective, Single-arm, Multi-center, Observational Study to Further Confirm Safety and Efficacy of the Dual-layer Micromesh Roadsaver Stent for the Treatment of Carotid Artery Stenosis in Patients Eligible for Elective Stenting Procedure
Enrollment Status: Completed
Publish Date: March 21, 2023
Intervention Type: Device
View 1 Less Clinical Trial

17 Total Publications

Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: October 21, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vulev's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile